us fda issues two 483s for lupin’s dabhasa unit
Published 8 years ago • 392 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
3:21
torrent pharma's gujarat facility gets u.s fda observation, lupin's tarapur unit gets warning letter
-
2:25
us fda issues 3 observations to lupin’s pithampur unit 3
-
2:22
lupin slips in trade as u.s fda issues warning letter for tarapur facility | chartbusters
-
20:41
chart buster | lupin's pithampur unit 1 receives eir from usfda | cnbc tv18
-
0:50
#shorts | usfda inspects pharma space
-
1:01:06
what to expect after an inspection: 483s, responses and beyond
-
4:42
indian pharma lupin's biggest market is also its biggest challenge, says md
-
5:59
'fed has room to cut' by 50 bps: analyst
-
2:31
u.s. fda issues 10 observations to aurobindo pharma under form 483 | halftime report | cnbc-tv18
-
21:37
halftime report | lupin gains 7% on eir from usfda for pithampur unit | cnbc tv18
-
2:17
us fda concerns hit lupin hard
-
10:00
usfda warning | lupin sees marginal impact on earnings; resolution to take 12-15 mths | cnbc tv18
-
0:49
usfda places global pharma health plant on import alert #shorts | cnbc-tv18
-
5:09
u.s. fda issues warning letter to lupin's two plants
-
2:13
lupin’s indore plant receives 6 us fda observations
-
2:33
usfda gives a clean chit to lupin's goa plant
-
2:05
u.s fda commences inspections of lupin and aurobindo pharma's facilities | halftime report
-
3:22
big drug approval | lupin gets a usfda approval for key respiratory drug gspiriva | cnbc tv18
-
2:57
lupin gets fda's nod for asthma drug gspiriva | cnbc tv18
-
18:15
lupin: us fda inspection at nagpur plant to start today | cnbc tv18
-
1:57
us drug regulator issues six observations to lupin's indore plant
-
0:36
dependent on generics which are most likely from india: us fda commissioner robert califf